Research Highlights

The University at Buffalo has officially launched the UB Biorepository, a critical new facility in the Clinical and Translational Research Center that will serve as a powerful resource in driving biomedical innovation in academia and industry regionally and throughout the state.

Pioneering research conducted and advanced by Paresh Dandona, MD, PhD, SUNY Distinguished Professor of medicine and chief of endocrinology, diabetes and metabolism, played a key role in the European Commission’s decision to approve dapagliflozin for patients with Type 1 diabetes.

Jacobs School of Medicine and Biomedical Sciences researchers have published results of the first randomized clinical trial of a treatment in the acute phase after a sport-related concussion.

Research by Yun Wu, PhD, assistant professor of biomedical engineering, has led to a cancer-spotting tool that health care providers could eventually use in areas that lack hospitals, clinics and other treatment centers.

Researchers in the Department of Physiology and Biophysics have developed a promising therapy for Duchenne muscular dystrophy (DMD) that is moving closer to use in humans.

The Jacobs School of Medicine and Biomedical Sciences is benefiting from the expansion of clinical trials in Western New York.

A comprehensive effort to boost clinical research at the University at Buffalo is paying off and community members are reaping the benefits through increased participation in clinical trials.

Researchers in the Department of Pathology and Anatomical Sciences have made surprising findings that challenge long-held scientific beliefs while studying the chewing behavior of carnivorans, the large mammalian order that includes dogs, cats and bears.

Michael D. Garrick, PhD, professor of biochemistry, was a member of the team that pioneered newborn screening programs worldwide.

Research on neutrophil extracellular traps (NETs) by Pinaki Sarder, PhD, assistant professor of pathology and anatomical sciences, is featured in Scientific Reports.